From SBA 7(a) loans to seller notes and equity roll-ups, here's how buyers are structuring deals in the $1M–$5M behavioral health space.
Behavioral health practices are among the most SBA-eligible healthcare businesses, but financing requires navigating credentialing continuity, key-person risk, and corporate practice of medicine structures. Most lower middle market deals combine an SBA 7(a) loan with seller financing and structured employment agreements to bridge valuation gaps and protect revenue during ownership transitions.
The most common financing vehicle for behavioral health acquisitions under $5M. Lenders underwrite based on payer mix stability, clinician retention, and historical collections rather than hard assets.
Pros
Cons
Sellers carry 10–20% of the purchase price as a subordinated note, often structured with a 2-year employment agreement ensuring clinical continuity and payer contract transferability during transition.
Pros
Cons
PE-backed behavioral health platforms acquire practices using equity with sellers rolling over 10–30% of deal value, creating alignment across a multi-site network with shared credentialing, billing, and HR infrastructure.
Pros
Cons
$2,500,000 (behavioral health group practice, $1.8M revenue, $380K EBITDA, 6.6x multiple)
Purchase Price
Approx. $22,800/month combined SBA and seller note debt service
Monthly Service
DSCR of approximately 1.38x based on $380K EBITDA, above the 1.25x minimum most SBA lenders require for healthcare acquisitions
DSCR
SBA 7(a) loan: $2,000,000 (80%) | Seller note at 7% over 5 years: $250,000 (10%) | Buyer equity injection: $250,000 (10%)
Yes, but lenders will require a mitigation plan. A 2-year seller employment agreement, documented patient transition protocols, and evidence of other credentialed clinicians on staff are typically required to approve the loan.
In CPOM states, you must acquire the management entity via an MSO structure, not the clinical practice itself. SBA lenders need to see that management fees flowing to the MSO are sufficient to service debt and are contractually documented.
Most SBA healthcare lenders require a minimum 15% EBITDA margin and DSCR of 1.25x or higher. Practices with high Medicaid concentration or owner-clinician revenue above 40% of collections often require compensating factors.
Yes. Seller notes of 10–20% are standard and often required by SBA lenders to demonstrate seller confidence. Notes are frequently tied to a 24-month transition period covering credentialing transfers and patient panel continuity milestones.
More Behavioral Health Practice Guides
DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers